Prospective randomized trial to compare the outcome and tolerability of delivering the same total dose of radiation in 61/2 weeks versus 51/2 weeks time in head and neck cancers

BACKGROUND: Concurrent chemoradiation is currently considered to be the standard of care in the treatment of head and neck cancer. In developing countries like ours, a good number of patients cannot tolerate chemoradiation because of the poor general condition and financial constraints. Those patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Manoj, Vats, Siddharth, Bhattacharyya, Tapesh, Seem, Rajeev K., Gupta, Manish, Mahajan, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
HEAD AND NECK CANCERS: Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756485/
https://www.ncbi.nlm.nih.gov/pubmed/26942141
http://dx.doi.org/10.4103/2278-330X.173168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756485/
https://www.ncbi.nlm.nih.gov/pubmed/26942141
http://dx.doi.org/10.4103/2278-330X.173168

Ejemplares similares